Symetryx Corp

10% OwnerNeuBase Therapeutics, Inc. (NBSE) · full profile →Form 4 · filed Sep 11, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$337K
Net Open-Market Flow
-$337K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2023Sell(S)3K$1.44$5K473K
Sep 8, 2023Sell(S)129K$1.53$197K476K
Sep 7, 2023Sell(S)75K$1.80$135K605K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001991925-23-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly: